Search research articles
Contact Us
Filters
Showing results (621-630 of 694) with videos related to
Page
of 70
Sort By:
Psychiatria Polska
|
October 16, 2014
[Autism spectrum disorders - epidemiology, symptoms, comorbidity and diagnosis]
Filip Rybakowski, Anna Bialek, Izabela Chojnicka, et al.
Genome Biology
|
April 19, 2026
The SMARCA4 subunit of the SWI/SNF complex prevents genome instability at G quadruplexes
Alison Harrod, Hugang Feng, Nagham Ghaddar, et al.
Science (New York, N.Y.)
|
June 27, 2024
Mef2d potentiates type-2 immune responses and allergic lung inflammation
Aydan C H Szeto, Paula A Clark, Ana C F Ferreira, et al.
Leukemia & Lymphoma
|
June 23, 2025
Pembrolizumab in relapsed or refractory Hodgkin lymphoma: a post hoc analysis of KEYNOTE-204 by prior lines of therapy
John Kuruvilla, Dipenkumar Modi, Armando Santoro, et al.
Annals of Hematology
|
July 1, 2023
Clinical efficacy and tolerability of venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia-a real-world analysis of the Polish Adult Leukemia Study Group
Anita Soboń, Joanna Drozd-Sokołowska, Ewa Paszkiewicz-Kozik, et al.
Scientific Reports
|
June 22, 2022
High efficacy of intensive immunochemotherapy for primary mediastinal B-cell lymphoma with prolonged follow up
Joanna Romejko-Jarosinska, Beata Ostrowska, Anna Dabrowska-Iwanicka, et al.
American Journal of Therapeutics
|
April 16, 2014
Polish Lymphoma Research Group Experience With Bexarotene in the Treatment of Cutaneous T-Cell Lymphoma
Malgorzata Sokolowska-Wojdylo, Aleksandra Florek, Jan Maciej Zaucha, et al.
Nature Communications
|
April 13, 2017
Genome assembly with in vitro proximity ligation data and whole-genome triplication in lettuce
Sebastian Reyes-Chin-Wo, Zhiwen Wang, Xinhua Yang, et al.
Annals of Hematology
|
February 24, 2021
High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin Lymphoma
Ryszard Swoboda, Sebastian Giebel, Wanda Knopińska-Posłuszny, et al.
Blood Advances
|
October 13, 2021
Quality-of-life analysis of pembrolizumab vs brentuximab vedotin for relapsed/refractory classical Hodgkin lymphoma
Pier Luigi Zinzani, Radhakrishnan Ramchandren, Armando Santoro, et al.
Page
of 70
Search research articles
Search
Showing results (621-630 of 694) with videos related to
Sort By:
Page
of 70
Psychiatria Polska
|
October 16, 2014
[Autism spectrum disorders - epidemiology, symptoms, comorbidity and diagnosis]
Filip Rybakowski, Anna Bialek, Izabela Chojnicka, et al.
Genome Biology
|
April 19, 2026
The SMARCA4 subunit of the SWI/SNF complex prevents genome instability at G quadruplexes
Alison Harrod, Hugang Feng, Nagham Ghaddar, et al.
Science (New York, N.Y.)
|
June 27, 2024
Mef2d potentiates type-2 immune responses and allergic lung inflammation
Aydan C H Szeto, Paula A Clark, Ana C F Ferreira, et al.
Leukemia & Lymphoma
|
June 23, 2025
Pembrolizumab in relapsed or refractory Hodgkin lymphoma: a post hoc analysis of KEYNOTE-204 by prior lines of therapy
John Kuruvilla, Dipenkumar Modi, Armando Santoro, et al.
Annals of Hematology
|
July 1, 2023
Clinical efficacy and tolerability of venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia-a real-world analysis of the Polish Adult Leukemia Study Group
Anita Soboń, Joanna Drozd-Sokołowska, Ewa Paszkiewicz-Kozik, et al.
Scientific Reports
|
June 22, 2022
High efficacy of intensive immunochemotherapy for primary mediastinal B-cell lymphoma with prolonged follow up
Joanna Romejko-Jarosinska, Beata Ostrowska, Anna Dabrowska-Iwanicka, et al.
American Journal of Therapeutics
|
April 16, 2014
Polish Lymphoma Research Group Experience With Bexarotene in the Treatment of Cutaneous T-Cell Lymphoma
Malgorzata Sokolowska-Wojdylo, Aleksandra Florek, Jan Maciej Zaucha, et al.
Nature Communications
|
April 13, 2017
Genome assembly with in vitro proximity ligation data and whole-genome triplication in lettuce
Sebastian Reyes-Chin-Wo, Zhiwen Wang, Xinhua Yang, et al.
Annals of Hematology
|
February 24, 2021
High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin Lymphoma
Ryszard Swoboda, Sebastian Giebel, Wanda Knopińska-Posłuszny, et al.
Blood Advances
|
October 13, 2021
Quality-of-life analysis of pembrolizumab vs brentuximab vedotin for relapsed/refractory classical Hodgkin lymphoma
Pier Luigi Zinzani, Radhakrishnan Ramchandren, Armando Santoro, et al.
Page
of 70